Hello, Fool! | Login | Signup | My Fool
Oct 11, 2008 12:55 AM ET | Feedback | Site Changes | Help
The Company is a developer, manufacturer and supplier of diagnostic and medical imaging systems primarily dedicated to serving the healthcare needs of women.
View Ticker Page (HOLX)
Results 1 - 10 of 101 : 12345Next »
Recs
LEGMAKER (< 20) Submitted: 5/12/08 10:04 AM : Start Price: $22.15 HOLX Score: 2.13
In the wake of an unsteady market, it is very important to look for defensive positions, or at least stocks that have steady revenue flow. The Healthcare sector looks to benefit from this. It is important to remember that no matter how bad things get...
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
AnomaLee (99.54) Submitted: 5/09/08 6:12 AM : Start Price: $22.52 HOLX Score: 0.84
I'm mostly just charting here close to its 52-wk low. Reading the risks from their 10-Q form was like reading the health risks associated with the latest blood pressure pills, and health care stocks are not for those with faint hearts. Management not...
slo1111 (54.94) Submitted: 1/18/07 2:35 PM : Start Price: $24.77 HOLX Score: -3.21
This company has high earnings growth targets to maintain PE ratio. Kicker is that they have consitenty been exceeding expectations and they have low debt and can continue to beat earnings expections by aquisition or organic market share growth. RO...
hoosiereagle (67.31) Submitted: 5/23/07 2:10 PM : Start Price: $26.39 HOLX Score: -2.53
Merger w/ CYTYC creates the dominant med-tech player in women's health. Combined they will be a $9B mkt cap. with 20% organic growth for the next five plus years based on digital mammo, tomosynthesis, mammosite and novasure plus a host of other pipe...
Firesale (< 20) Submitted: 6/20/07 2:41 PM : Start Price: $27.75 HOLX Score: -5.58
Revenue growth at 81%, a P/E of 61, but next years’ earnings drops it to 28, and Hologic consistently beats the street's estimated earnings. The company continues to grow through acquisition and internally, and although the company denies that it wi...
tostradamus (74.11) Submitted: 10/15/07 1:42 PM : Start Price: $32.24 HOLX Score: -11.64
This company is going to be huge after the merger. They'll deal with all women's health issues and women have a far greater propensity to consult a doctor for everything. Stick it in your IRA.
TMFSarahGen (99.84) Submitted: 7/02/08 4:46 PM : Start Price: $22.77 HOLX Score: -0.52
Excellent company that specializes in women's healthcare. Overly punished for a tough integration with the massive acquisition of Cytec. Both Hologic and Cytec have had cutting edge solutions that improve women's healthcare. Even bigger winner now...
jyoung12387 (73.85) Submitted: 11/12/07 7:10 PM : Start Price: $30.77 HOLX Score: -13.47
As i wrote in my blog on www.StockpickerJason.com , I believe this stock is too cheap at $61. The company as good EPS growth, improving margins, and I believe it will see some multiple expansion. HOLX is guiding Gross Margin to 61-62%, which is a hug...
SESAMEnow (60.51) Submitted: 12/29/07 6:33 PM : Start Price: $34.63 HOLX Score: -18.03
Looks like a good investiment appears to be undervalued in current market.Disclosure: I own no shares of this stock.
grania4114 (< 20) Submitted: 8/11/08 11:13 AM : Start Price: $20.73 HOLX Score: 2.40
Merger with Cystyc has had its bumps and will show great benefit when combined with the pruchase of Third Wave and its Invader technology. The marriage of ThinPrep and TWT's HPV testing will be a growth driver with recurring income for the forceable...